Ashvinikumar V. Gavai

942 citations

25 papers · 442 indexed · h-index 14

Co-authors: E. J. Corey Edward Piers Gregory D. Vite Brian E. Fink Tai W. Wong Harold Mastalerz Hongjian Zhang Simone Oppenheimer
Topics: HER2/EGFR in Cancer Research (6 papers)Chemical Synthesis and Analysis (5 papers)Synthetic Organic Chemistry Methods (4 papers)
Cited by: Organic Chemistry Oncology Pharmacology
Journals: Cancer Research Clinical Cancer Research The Journal of Organic Chemistry
Partner nations: United States Germany Canada

In The Last Decade

Ashvinikumar V. Gavai

24 papers receiving 417 citations

Peers

Countries citing papers authored by Ashvinikumar V. Gavai

Since Specialization

Citations

This map shows the geographic impact of Ashvinikumar V. Gavai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashvinikumar V. Gavai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashvinikumar V. Gavai more than expected).

Fields of papers citing papers by Ashvinikumar V. Gavai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashvinikumar V. Gavai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashvinikumar V. Gavai. The network helps show where Ashvinikumar V. Gavai may publish in the future.

Co-authorship network of co-authors of Ashvinikumar V. Gavai

This figure shows the co-authorship network connecting the top 25 collaborators of Ashvinikumar V. Gavai. A scholar is included among the top collaborators of Ashvinikumar V. Gavai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashvinikumar V. Gavai. Ashvinikumar V. Gavai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer 2018 ·Annals of Oncology ·John Hilton,Mihaela Cristea,Mark Voskoboynik,Sophie Postel‐Vinay,William J. Edenfield,Ashvinikumar V. Gavai,Susan Wee,(unknown),Anke Klippel,(unknown),(unknown),Scott D. Chasalow,Daphne Williams,Mark Donovan,(unknown),Sophia K. Khaldoyanidi,Jennifer R. Diamond	15
2	Abstract 5792: Preclinical antitumor activity of BMS-986158, an oral BET inhibitor, for the treatment of cancer 2018 ·Cancer Research ·Susan Wee,Donald Jackson,Heshani Desilva,Maya Dajee,Julie Carman,Petra Ross‐Macdonald,Jinping Gan,Richard A. Westhouse,Christine Huang,Zheng Yang,Michael A. Poss,John T. Hunt,Gregory D. Vite,Ashvinikumar V. Gavai	0
3	[2.2.1]-Bicyclic sultams as potent androgen receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·Weifang Shan,Aaron Balog,(unknown),Xiao Zhu,Jing Chen,Mary Ellen Cvijic,Jieping Geng,Cheryl A. Rizzo,Thomas Spires,Ricardo M. Attar,Mary T. Obermeier,Sarah C. Traeger,Jun Dai,Yingru Zhang,Michael A. Galella,George L. Trainor,Gregory D. Vite,Ashvinikumar V. Gavai	11
4	A Practical Approach for Enantio- and Diastereocontrol in the Synthesis of 2,3-Disubstituted Succinic Acid Esters: Synthesis of the pan-Notch Inhibitor BMS-906024 2016 ·Synlett ·Claude Quesnelle,Patrice Gill,Soong‐Hoon Kim,Libing Chen,Yufen Zhao,Brian E. Fink,Mark G. Saulnier,David B. Frennesson,Michael P. DeMartino,Phil S. Baran,Ashvinikumar V. Gavai	5
5	Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families 2011 ·Clinical Cancer Research ·Tai W. Wong,Francis Y. Lee,Stuart L. Emanuel,Craig R. Fairchild,Joseph Fargnoli,Brian E. Fink,Ashvinikumar V. Gavai,(unknown),Benjamin J. Henley,(unknown),John T. Hunt,Bala Krishnan,Daniel Kukral,Anne Lewin,(unknown),Derek Norris,Simone Oppenheimer,Gregory D. Vite,Chiang Yu	18
6	Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2 2010 ·Journal of Pharmaceutical Sciences ·Punit Marathe,(unknown),Bogdan Sleczka,David Rodrigues,Ashvinikumar V. Gavai,Tai‐Tong Wong,Lisa J. Christopher,Hongjian Zhang	16
7	Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases 2010 ·Bioorganic & Medicinal Chemistry Letters ·Brian E. Fink,Derek Norris,Harold Mastalerz,Ping Chen,Bindu Goyal,Yufen Zhao,Soong‐Hoon Kim,Gregory D. Vite,Francis Y. Lee,Hongjian Zhang,Simone Oppenheimer,John S. Tokarski,Tai W. Wong,Ashvinikumar V. Gavai	23
8	Design and Synthesis of a G-Protein-Coupled Receptor Antagonist Library of Aryloxyalkanolamines Using a Polymer-Supported Acyclic Acetal Linker 2008 ·Journal of Combinatorial Chemistry ·Jacques Y. Roberge,Lalgudi S. Harikrishnan,(unknown),Zheming Ruan,(unknown),Yalei Liu,Christopher B. Cooper,Michael A. Poss,John K. Dickson,Ashvinikumar V. Gavai,Sam Chao,Leslie Leith,Mark S. Bednarz,Arvind Mathur,Ramesh Kakarla,Dora M. Schnur,Roy J. Vaz,R. Michael Lawrence	4
9	290 POSTER Pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Aurora kinases 2008 ·European Journal of Cancer Supplements ·Ashvinikumar V. Gavai,Derek Norris,George L. Trainor,Gregory D. Vite,Yaxue Zhao,Dolatrai M. Vyas,John S. Tokarski,Wen‐Ge Han,Tai‐Tong Wong,Brent Rupnow	1
10	Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases 2007 ·Bioorganic & Medicinal Chemistry Letters ·Harold Mastalerz,Ming Chang,Ashvinikumar V. Gavai,Walter L. Johnson,David R. Langley,Francis Y. Lee,Punit Marathe,Arvind Mathur,Simone Oppenheimer,(unknown),John S. Tokarski,Gregory D. Vite,Dolatrai M. Vyas,Henry Ν. C. Wong,Tai W. Wong,Hongjian Zhang,Guifen Zhang	24
11	Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3 2006 ·Bioorganic & Medicinal Chemistry Letters ·Brian E. Fink,Ashvinikumar V. Gavai,John S. Tokarski,Bindu Goyal,Raj N. Misra,Hai‐Yun Xiao,S. David Kimball,Wen-Ching Han,Derek Norris,Thomas Spires,Dan You,Marco M. Gottardis,Matthew V. Lorenzi,Gregory D. Vite	36
12	Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling 2006 ·Clinical Cancer Research ·Tai W. Wong,Francis Y. Lee,Chiang Yu,Feng Luo,Simone Oppenheimer,Hongjian Zhang,Richard Smykla,Harold Mastalerz,Brian E. Fink,John T. Hunt,Ashvinikumar V. Gavai,Gregory D. Vite	65
13	Discovery of Novel 1‐Arylmethyl Pyrrolidin‐2‐yl Ethanol Amines as Calcium‐Sensing Receptor Antagonists. 2006 ·ChemInform ·Ashvinikumar V. Gavai,(unknown)	2
14	Pyrrolotriazine-5-carboxylate ester inhibitors of EGFR and HER2 protein tyrosine kinases and a novel one-pot synthesis of C-4 subsitituted pyrrole-2,3-dicarboxylate diesters 2006 ·Canadian Journal of Chemistry ·Harold Mastalerz,Ashvinikumar V. Gavai,Brian E. Fink,(unknown),(unknown),Gregory D. Vite,Tai W. Wong,Guifen Zhang,Dolatrai M. Vyas	12
15	Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Ashvinikumar V. Gavai,Roy J. Vaz,Amarendra B. Mikkilineni,Jacques Y. Roberge,Yalei Liu,R. Michael Lawrence,James R. Corte,Wu Yang,Mark S. Bednarz,John K. Dickson,Zhengping Ma,Ramakrishna Seethala,Jean H.M. Feyen	22
16	A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series 2005 ·Bioorganic & Medicinal Chemistry Letters ·Roy J. Vaz,Akbar Nayeem,Kenneth S. Santone,Gamini Chandrasena,Ashvinikumar V. Gavai	18
17	A (Z)-ethylidenecyclopentane annulation method. Total syntheses of (.+-.)-anhydrooplopanone, (.+-.)-oplopanone, and (.+-.)-8-epi-oplopanone 1990 ·The Journal of Organic Chemistry ·Edward Piers,Ashvinikumar V. Gavai	29
18	Stereospecific deconjugation of alkyl (E)- and (Z)-3-trimethylstannyl-2-alkenoates 1990 ·The Journal of Organic Chemistry ·Edward Piers,Ashvinikumar V. Gavai	24
19	Simple analogs of ginkgolide b which are highly active antagonists of platelet activating factor 1989 ·Tetrahedron Letters ·E. J. Corey,Ashvinikumar V. Gavai	25
20	Stereospecific protonative deconjugation of alkyl 3-trimethylstannylalk-2-enoates 1985 ·Journal of the Chemical Society Chemical Communications ·Edward Piers,Ashvinikumar V. Gavai	5

About Ashvinikumar V. Gavai

Ashvinikumar V. Gavai is a scholar working on Organic Chemistry, Biochemistry and Pharmacology, having authored 25 papers that have together received 442 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Synthetic Organic Chemistry Methods (4 papers). The work is most often cited by research in Organic Chemistry (203 citations), Oncology (122 citations) and Pharmacology (31 citations). Ashvinikumar V. Gavai has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include E. J. Corey, Edward Piers, Gregory D. Vite, Brian E. Fink, Tai W. Wong, Harold Mastalerz, Hongjian Zhang, Simone Oppenheimer, Francis Y. Lee and John S. Tokarski. Their work appears in journals such as Cancer Research, Clinical Cancer Research and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact